Jefferies Group LLC set a $77.00 price objective on Cardinal Health, Inc. (NYSE:CAH) in a research report sent to investors on Tuesday. The brokerage currently has a hold rating on the stock.

Other equities research analysts have also recently issued research reports about the stock. Vetr raised shares of Cardinal Health from a hold rating to a buy rating and set a $77.92 price target for the company in a research report on Tuesday, June 13th. BidaskClub cut shares of Cardinal Health from a strong-buy rating to a buy rating in a research report on Tuesday, July 11th. Credit Suisse Group reaffirmed a buy rating and issued a $81.00 price target on shares of Cardinal Health in a research report on Tuesday, May 2nd. Zacks Investment Research raised shares of Cardinal Health from a strong sell rating to a hold rating in a research report on Tuesday, June 20th. Finally, ValuEngine cut shares of Cardinal Health from a buy rating to a hold rating in a research report on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the company. The company has an average rating of Hold and a consensus target price of $80.46.

Cardinal Health (NYSE:CAH) opened at 67.82 on Tuesday. The company has a market cap of $21.46 billion, a PE ratio of 16.83 and a beta of 0.86. Cardinal Health has a 1-year low of $62.70 and a 1-year high of $84.88. The company has a 50-day moving average price of $70.74 and a 200-day moving average price of $75.84.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The firm had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. During the same quarter in the prior year, the company earned $1.14 EPS. The company’s revenue was up 5.0% compared to the same quarter last year. On average, analysts expect that Cardinal Health will post $4.96 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.watchlistnews.com/cardinal-health-inc-cah-given-a-77-00-price-target-at-jefferies-group-llc/1537516.html.

The business also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Shareholders of record on Monday, October 2nd will be issued a $0.4624 dividend. The ex-dividend date of this dividend is Friday, September 29th. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.73%. Cardinal Health’s dividend payout ratio is currently 45.79%.

Several hedge funds and other institutional investors have recently bought and sold shares of CAH. Advisory Services Network LLC bought a new position in Cardinal Health during the first quarter worth about $120,000. Bronfman E.L. Rothschild L.P. boosted its position in Cardinal Health by 31.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock worth $123,000 after buying an additional 382 shares in the last quarter. JFS Wealth Advisors LLC boosted its position in Cardinal Health by 14.3% in the second quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock worth $152,000 after buying an additional 244 shares in the last quarter. Dupont Capital Management Corp bought a new position in Cardinal Health during the second quarter worth about $164,000. Finally, First Personal Financial Services boosted its position in Cardinal Health by 127.5% in the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock worth $172,000 after buying an additional 1,238 shares in the last quarter. 87.66% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.